Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects.

This study could open new avenues for the improvement of therapeutic efficacy of Sorafenib treated HCC patients by using Tau in combination. PMID: 31653148 [PubMed - in process]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research